Simulations Plus Research and Development Expenses 2010-2024 | SLP
Simulations Plus research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Simulations Plus Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$6 |
| 2023 |
$5 |
| 2022 |
$3 |
| 2021 |
$4 |
| 2020 |
$3 |
| 2019 |
$3 |
| 2018 |
$2 |
| 2017 |
$1 |
| 2016 |
$1 |
| 2015 |
$1 |
| 2014 |
$1 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$0 |
| 2010 |
$1 |
| 2009 |
$1 |
Simulations Plus Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-08-31 |
$2 |
| 2024-05-31 |
$1 |
| 2024-02-29 |
$1 |
| 2023-11-30 |
$1 |
| 2023-08-31 |
$1 |
| 2023-05-31 |
$1 |
| 2023-02-28 |
$1 |
| 2022-11-30 |
$1 |
| 2022-08-31 |
$1 |
| 2022-05-31 |
$1 |
| 2022-02-28 |
$1 |
| 2021-11-30 |
$1 |
| 2021-08-31 |
$1 |
| 2021-05-31 |
$1 |
| 2021-02-28 |
$1 |
| 2020-11-30 |
$1 |
| 2020-08-31 |
$1 |
| 2020-05-31 |
$1 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
$1 |
| 2019-05-31 |
$1 |
| 2019-02-28 |
$1 |
| 2018-11-30 |
$1 |
| 2018-08-31 |
$0 |
| 2018-05-31 |
$1 |
| 2018-02-28 |
$0 |
| 2017-11-30 |
$0 |
| 2017-08-31 |
$0 |
| 2017-05-31 |
$0 |
| 2017-02-28 |
$0 |
| 2016-11-30 |
$0 |
| 2016-08-31 |
$0 |
| 2016-05-31 |
$0 |
| 2016-02-29 |
$0 |
| 2015-11-30 |
$0 |
| 2015-08-31 |
$0 |
| 2015-05-31 |
$0 |
| 2015-02-28 |
$0 |
| 2014-11-30 |
$0 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$0 |
| 2014-02-28 |
$0 |
| 2013-11-30 |
$0 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$0 |
| 2013-02-28 |
$0 |
| 2012-11-30 |
$0 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$0 |
| 2012-02-29 |
$0 |
| 2011-11-30 |
$0 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$0 |
| 2011-02-28 |
$0 |
| 2010-11-30 |
$0 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$0 |
| 2010-02-28 |
$0 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$0 |
| 2009-02-28 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.552B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
